Skip to Content

APO R4.5 (Rivastigmine tartrate 4.5 mg)

Pill with imprint APO R4.5 is Red, Capsule-shape and has been identified as Rivastigmine tartrate 4.5 mg. It is supplied by Apotex Corp..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for APO R4.5

Rivastigmine tartrate

Imprint:
APO R4.5
Strength:
4.5 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-3222

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide